Home > Boards > US Listed > Biotechs > Clearside BioMedical, Inc. (CLSD)

NDA accepted by FDA

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BioSpecialist Member Profile
 
Followed By 120
Posts 2,381
Boards Moderated 1
Alias Born 12/27/07
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/20/2021 6:20:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/20/2021 6:19:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/20/2021 6:18:10 PM
Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension... GlobeNewswire Inc. - 1/12/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/8/2021 8:20:05 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/7/2021 4:17:02 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/7/2021 11:11:27 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/7/2021 9:49:45 AM
Clearside Biomedical Announces Pricing of $12 Million Registered Direct Offering GlobeNewswire Inc. - 1/6/2021 7:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/28/2020 10:31:41 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/23/2020 4:29:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/24/2020 4:56:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/16/2020 4:38:19 PM
Clearside Biomedical Announces Data Presentations at the American Academy Ophthalmology (AAO) 2020 Annual Meeting and Publica... GlobeNewswire Inc. - 11/16/2020 7:05:00 AM
Clearside Biomedical to Present at the Stifel 2020 Virtual Healthcare Conference GlobeNewswire Inc. - 11/11/2020 7:05:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2020 5:16:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/10/2020 4:16:31 PM
Clearside Biomedical Announces Third Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 11/10/2020 4:05:00 PM
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 202... GlobeNewswire Inc. - 10/30/2020 7:05:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/24/2020 4:43:09 PM
Clearside Biomedical Announces Clinical Data Presentations at The Retina Society 2020 and Publication of XIPERE™ Data in Di... GlobeNewswire Inc. - 9/23/2020 7:05:10 AM
Clearside Biomedical’s Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melan... GlobeNewswire Inc. - 9/11/2020 8:30:10 AM
Clearside Biomedical to Present at the Virtual H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2020 4:05:10 PM
Clearside Biomedical’s Licensing Partner Doses First Patient in its Phase 2 Gene Therapy Trial Using SCS Microinjector® fo... GlobeNewswire Inc. - 9/9/2020 8:30:10 AM
Clearside Biomedical Expands Patent Portfolio in the U.S. and Europe GlobeNewswire Inc. - 8/26/2020 7:05:10 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences